|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Selim JH, Shaheen S, Sheu WC and Hsueh CT:
Targeted and novel therapy in advanced gastric cancer. Exp Hematol
Oncol. 8:252019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Digklia A and Wagner AD: Advanced gastric
cancer: Current treatment landscape and future perspectives. World
J Gastroenterol. 22:2403–2414. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maehara Y, Hasuda S, Koga T, Tokunaga E,
Kakeji Y and Sugimachi K: Postoperative outcome and sites of
recurrence in patients following curative resection of gastric
cancer. Br J Surg. 87:353–357. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nagano T and Fraser P: No-nonsense
functions for long noncoding RNAs. Cell. 145:178–181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ishii N, Ozaki K, Sato H, Mizuno H, Saito
S, Takahashi A, Miyamoto Y, Ikegawa S, Kamatani N, Hori M, et al:
Identification of a novel non-coding RNA, MIAT, that confers risk
of myocardial infarction. J Hum Genet. 51:1087–1099. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang R, Zhao L, Ji L, Bai L and Wen Q:
Myocardial infarction associated transcript (MIAT) promotes
papillary thyroid cancer progression via sponging miR-212. Biomed
Pharmacother. 118:1092982019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin D, Xu HP, Lin JH, Hu HH, Wang Q and
Zhang J: Long non-coding RNA MIAT promotes non-small cell lung
cancer progression by sponging miR-1246. Eur Rev Med Pharmacol Sci.
23:5795–5801. 2019.PubMed/NCBI
|
|
9
|
Liu Z, Wang H, Cai H, Hong Y, Li Y, Su D
and Fan Z: Long non-coding RNA MIAT promotes growth and metastasis
of colorectal cancer cells through regulation of miR-132/Derlin-1
pathway. Cancer Cell Int. 18:592018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Thomson DW and Dinger ME: Endogenous
microRNA sponges: Evidence and controversy. Nat Rev Genet.
17:272–283. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen X, Luo H, Li X, Tian X, Peng B, Liu
S, Zhan T, Wan Y, Chen W, Li Y, et al: miR-331-3p functions as an
oncogene by targeting ST7L in pancreatic cancer. Carcinogenesis.
39:1006–1015. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Buranjiang G, Kuerban R, Abuduwanke A, Li
X and Kuerban G: MicroRNA-331-3p inhibits proliferation and
metastasis of ovarian cancer by targeting RCC2. Arch Med Sci.
15:1520–1529. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao D, Sui Y and Zheng X: MiR-331-3p
inhibits proliferation and promotes apoptosis by targeting HER2
through the PI3K/Akt and ERK1/2 pathways in colorectal cancer.
Oncol Rep. 35:1075–1082. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo X, Guo L, Ji J, Zhang J, Zhang J, Chen
X, Cai Q, Li J, Gu Q, Liu B, et al: miRNA-331-3p directly targets
E2F1 and induces growth arrest in human gastric cancer. Biochem
Biophys Res Commun. 398:1–6. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Daitoku H, Isida J, Fujiwara K, Nakajima T
and Fukamizu A: Dimerization of small GTPase Rab5. Int J Mol Med.
8:397–404. 2001.PubMed/NCBI
|
|
17
|
Igarashi T, Araki K, Yokobori T, Altan B,
Yamanaka T, Ishii N, Tsukagoshi M, Watanabe A, Kubo N, Handa T, et
al: Association of RAB5 overexpression in pancreatic cancer with
cancer progression and poor prognosis via E-cadherin suppression.
Oncotarget. 8:12290–12300. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang PS, Yin PH, Tseng LM, Yang CH, Hsu
CY, Lee MY, Horng CF and Chi CW: Rab5A is associated with axillary
lymph node metastasis in breast cancer patients. Cancer Sci.
102:2172–2178. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao Z, Liu XF, Wu HC, Zou SB, Wang JY, Ni
PH, Chen XH and Fan QS: Rab5a overexpression promoting ovarian
cancer cell proliferation may be associated with APPL1-related
epidermal growth factor signaling pathway. Cancer Sci.
101:1454–1462. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
R Core Team, . R: A language and
environment for statistical computing. R Foundation for Statistical
Computing; Vienna: 2011
|
|
22
|
RStudio Team, . Integrated development
environment for R. RStudio, PBC; Boston, MA: 2015
|
|
23
|
Camacho CV, Choudhari R and Gadad SS: Long
noncoding RNAs and cancer, an overview. Steroids. 133:93–95. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang G, Li X, Song L, Pan H, Jiang J and
Sun L: Long noncoding RNA MIAT promotes the progression of acute
myeloid leukemia by negatively regulating miR-495. Leuk Res.
87:1062652019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sha M, Lin M, Wang J, Ye J, Xu J, Xu N and
Huang J: Long non-coding RNA MIAT promotes gastric cancer growth
and metastasis through regulation of miR-141/DDX5 pathway. J Exp
Clin Cancer Res. 37:582018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ai W, Li F, Yu HH, Liang ZH and Zhao HP:
Up-regulation of long noncoding RNA LINC00858 is associated with
poor prognosis in gastric cancer. J Gene Med. 22:e31492020.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chan JJ and Tay Y: Noncoding RNA:RNA
regulatory networks in cancer. Int J Mol Sci. 19:13102018.
View Article : Google Scholar
|
|
28
|
Huang Y, Sun H, Ma X, Zeng Y, Pan Y, Yu D,
Liu Z and Xiang Y: HLA-F-AS1/miR-330-3p/PFN1 axis promotes
colorectal cancer progression. Life Sci. 254:1171802020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qu L, Ding J, Chen C, Wu ZJ, Liu B, Gao Y,
Chen W, Liu F, Sun W, Li XF, et al: Exosome-transmitted lncARSR
promotes sunitinib resistance in renal cancer by acting as a
competing endogenous RNA. Cancer Cell. 29:653–668. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Y, Wang K, Wei Y, Yao Q, Zhang Q, Qu H
and Zhu G: lncRNA-MIAT regulates cell biological behaviors in
gastric cancer through a mechanism involving the miR-29a-3p/HDAC4
axis. Oncol Rep. 38:3465–3472. 2017.PubMed/NCBI
|
|
31
|
Xuefang Z, Ruinian Z, Liji J, Chun Z,
Qiaolan Z, Jun J, Yuming C and Junrong H: miR-331-3p inhibits
proliferation and promotes apoptosis of nasopharyngeal carcinoma
cells by targeting elf4B-PI3K-AKT pathway. Technol Cancer Res
Treat. 19:15330338198922512020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhao M, Zhang M, Tao Z, Cao J, Wang L and
Hu X: miR-331-3p suppresses cell proliferation in TNBC cells by
downregulating NRP2. Technol Cancer Res Treat.
19:15330338209058242020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chua CE and Tang BL: The role of the small
GTPase Rab31 in cancer. J Cell Mol Med. 19:1–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wilson DB and Wilson MP: Identification
and subcellular localization of human rab5b, a new member of the
ras-related superfamily of GTPases. J Clin Invest. 89:996–1005.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Stenmark H: Rab GTPases as coordinators of
vesicle traffic. Nat Rev Mol Cell Biol. 10:513–525. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Takeda M, Koseki J, Takahashi H, Miyoshi
N, Nishida N, Nishimura J, Hata T, Matsuda C, Mizushima T, Yamamoto
H, et al: Disruption of endolysosomal RAB5/7 efficiently eliminates
colorectal cancer stem cells. Cancer Res. 79:1426–1437. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Peinado H, Alečković M, Lavotshkin S,
Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M,
Williams C, García-Santos G, Ghajar C, et al: Melanoma exosomes
educate bone marrow progenitor cells toward a pro-metastatic
phenotype through MET. Nat Med. 18:883–891. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Díaz J, Mendoza P, Ortiz R, Díaz N, Leyton
L, Stupack D, Quest AFG and Torres VA: Rab5 is required in
metastatic cancer cells for Caveolin-1-enhanced Rac1 activation,
migration and invasion. J Cell Sci. 127:2401–2406. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kong X, Zhang J, Li J, Shao J and Fang L:
MiR-130a-3p inhibits migration and invasion by regulating RAB5B in
human breast cancer stem cell-like cells. Biochem Biophys Res
Commun. 501:486–493. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang FW, Cao CH, Han K, Zhao YX, Cai MY,
Xiang ZC, Zhang JX, Chen JW, Zhong LP, Huang Y, et al:
APC-activated long noncoding RNA inhibits colorectal carcinoma
pathogenesis through reduction of exosome production. J Clin
Invest. 129:727–743. 2019. View Article : Google Scholar : PubMed/NCBI
|
